Price History
Feb 9, 2026 — Apr 4, 2026Investment Snapshot
- Trading 54% above Graham Number — above intrinsic value estimate
- Piotroski F-Score 5/9 — moderate financial health
- Strong ROE of 30.1% with 12.4% net margin
Vontier Corp (VNT) is a Healthcare company operating in Totalizing Fluid Meters & Counting Devices, listed on the NYSE , with a market capitalisation of $5.0 billion . Key value metrics: P/E ratio 13.3, P/B ratio 4.01, Piotroski F-Score 5 out of 9 (moderate financial health) .
Value Score
Key Metrics
Current vs 5-Year Average
Based on 5 years of SEC filingsRevenue & Net Income
Financial Statements
| Metric | FY22 | FY23 | FY24 |
|---|---|---|---|
| Revenue | $X.XB | $X.XB | $X.XB |
| Gross Profit | $X.XB | $X.XB | $X.XB |
| Operating Income | $X.XB | $X.XB | $X.XB |
| Net Income | $X.XB | $X.XB | $X.XB |
| EBITDA | $X.XB | $X.XB | $X.XB |
| Total Assets | $X.XB | $X.XB | $X.XB |
| Total Liabilities | $X.XB | $X.XB | $X.XB |
Vontier Corp — Fundamental Analysis Summary
Vontier Corp (VNT) is currently trading 54% above its Graham Number of $22.86, suggesting the market price exceeds Benjamin Graham's intrinsic value estimate. The stock carries a reasonable trailing P/E ratio of 13.3x.
On financial health, VNT shows a moderate Piotroski F-Score of 5/9, and strong return on equity of 30.1% (sector average: -19.8%), and elevated leverage with a debt-to-equity ratio of 1.68.
StockPik's composite Value Score for VNT is 77/100 — placing it in undervalued territory. The score is built from ten fundamental signals: P/E, P/B, PEG ratio, P/S ratio, return on equity, gross margin, debt-to-equity, current ratio, dividend yield, and Piotroski F-Score.
VNT reports a solid gross margin of 47.4% (sector average: 33.5%) and a solid operating margin of 17.9%.
VNT shows revenue growing at 3% year-over-year, with earnings declining at 4%.
VNT pays a modest dividend yield of 0.3%.